четверг, 21 января 2016 г.

Watchlist 1/21/2016

$AGEN - Announces FDA clearance of 2 new investigational drug applications.
FDA cleared the company's investigational new drug application for AGEN1884, an immune checkpoint modulator antibody that binds to cytotoxic T-lymphocyte antigen-4
  • Clearance was also received for a second CPM antibody, co partnered with Incyte for INCAGN1876, targets glucocorticoid-induced TNFR-related protein.
  • Clinical trials for both candidates are expected to begin in the first half of 2016. 
Will watch for a short opportunity.

I also have $MNKD on watch, Co announced that it has entered into collaboration and license agreement with newly formed entity, Receptor Life Sciences, Inc. Co is eligible to receive development and commercialization milestones of up to $102.25 million.

Looking to short if it gives me a setup. 

Комментариев нет:

Отправить комментарий